Life Sciences Castle Biosciences Completes Acquisition of AltheaDx AIT News Desk Apr 27, 2022 Acquisition expands Castle’s estimated U.S. TAM by approximately $5.0 billion to $8.0 billion Castle also announces expanded Medicare coverage…
Diagnosis Castle Biosciences to Acquire AltheaDx AIT News Desk Apr 6, 2022 Furthers mid- and long-term growth with strategic advance into pharmacogenomics and mental health Castle executive management to host…